Stealth BioTherapeutics Appoints David A. Brown, Ph.D., as Chief Scientific Officer to Advance the Company's Pioneering Work in Mitochondrial Medicine
– Brown brings more than 20 years of experience in mitochondrial research and scientific team leadership – – Appointment signals expansion of executive team to support a growing proprietary pipeline in rare and age-related diseases of mitochondrial dysfunction – NEEDHAM, Mass., April 8,...
CP
cision pr newswire
via Pr Newswire - Corroborated by 1 others
Updated 1h ago
Source Verification
Corroboration Score: 2This story was independently reported by 2 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
FIU brings together federal and academic leaders in Washington to discuss AI's role in health care
Next
Insta360 releases USB-C selfie screen it's calling Snap
Related Articles
HealthIf You Feel Lonely, This Simple 3-Word Phrase Will Help You Move Past It, Therapist Says
Today-13h ago-1 sources
HealthLess than 10 percent now smoke, but we’re still far from finished
The Hill-13h ago-1 sources
HealthKiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis
Benzinga-13h ago-1 sources